FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

34962711000001100: Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Dec 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106039301000001110 Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106039401000001119 Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Is a Co-amoxiclav 250mg/125mg tablets 21 tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has AMP Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier 2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier 1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has presentation strength numerator value 125 false Inferred relationship Existential restriction modifier 1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has presentation strength numerator value 250 false Inferred relationship Existential restriction modifier 2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start